<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02445820</url>
  </required_header>
  <id_info>
    <org_study_id>ANES2015002</org_study_id>
    <nct_id>NCT02445820</nct_id>
  </id_info>
  <brief_title>HES and Acute Kidney Injury in Adult Cardiac Surgery</brief_title>
  <official_title>The Association Between Hydroxyethyl Starch 130/0.4 and Acute Kidney Injury After Cardiopulmonary Bypass: a Single-center Retrospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital of Liege</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital of Liege</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study retrospectively assess the effect or using balanced hydroxyethyl sctarch (HES)
      130/0.4 or a balanced crystalloid solution as a pump prime and for intraoperative fluid
      therapy on the risk of early acute postoperative kidney injury in adult cardiac surgery
      patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Actual">July 2015</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>AKIN SCr</measure>
    <time_frame>Forty eight hours</time_frame>
    <description>Stage of acute kidney injury using the Acute Kidney Injury Network Classification omitting the diuresis criteria.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>AKIN SCr+UO</measure>
    <time_frame>Forty eight hours</time_frame>
    <description>Stage of acute kidney injury using the Acute Kidney Injury Network Classification including the diuresis criteria.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative dialysis</measure>
    <time_frame>30 days</time_frame>
    <description>Requirement of postoperative renal replacement therapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory complication</measure>
    <time_frame>30 days</time_frame>
    <description>Need for reintubation, non-invasive ventilation or prolonged intensive care unit stay as a consequence of atelectasis, pulmonary edema or pneumonia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU stay</measure>
    <time_frame>30 days</time_frame>
    <description>Length of stay at the intensive care unit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay</measure>
    <time_frame>30 days</time_frame>
    <description>Length of stay at the hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30-day mortality</measure>
    <time_frame>30 days</time_frame>
    <description>Death in hospital or within 30 days of surgery</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">697</enrollment>
  <condition>Acute Kidney Injury After Adult Cardiac Surgery</condition>
  <arm_group>
    <arm_group_label>HES</arm_group_label>
    <description>Balanced HES 130/0.4 used as and pump prime and for intraoperative fluid therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Crystalloid</arm_group_label>
    <description>Balanced Crystalloid used as a pump prime and for intraoperative fluid therapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>HES</intervention_name>
    <description>2500 mL of balanced HES 130/0.4</description>
    <arm_group_label>HES</arm_group_label>
    <other_name>Volulyte®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Crystalloid</intervention_name>
    <description>2500 mL of balanced crystalloid.</description>
    <arm_group_label>Crystalloid</arm_group_label>
    <other_name>Plasmalyte A ®</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adults patients undergoing cardiac surgery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 18 yo

          -  Having on pump cardiac surgery at CHU of Liège between April 2013 and June 2014

        Exclusion Criteria:

          -  Off pump surgery

          -  Use of Blood or Albumin in the cardiopulmonary bypass priming solution

          -  Preoperative dialysis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 5, 2015</study_first_submitted>
  <study_first_submitted_qc>May 12, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 15, 2015</study_first_posted>
  <last_update_submitted>October 29, 2015</last_update_submitted>
  <last_update_submitted_qc>October 29, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 30, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital of Liege</investigator_affiliation>
    <investigator_full_name>Jean François Brichant</investigator_full_name>
    <investigator_title>Professor of Anesthesia and Intensive Care Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

